|
LOC100128191 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91799909288193E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.78677122781346E-12 |
| Normal-vs-Stage2 |
2.17750000000017E-05 |
| Normal-vs-Stage3 |
5.3712000402939E-09 |
| Normal-vs-Stage4 |
4.20970000003518E-06 |
| Stage1-vs-Stage2 |
6.407000E-01 |
| Stage1-vs-Stage3 |
5.764400E-01 |
| Stage1-vs-Stage4 |
8.875400E-01 |
| Stage2-vs-Stage3 |
4.829000E-01 |
| Stage2-vs-Stage4 |
6.851800E-01 |
| Stage3-vs-Stage4 |
8.454800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.14799314288439E-12 |
| Normal-vs-AfricanAmerican |
8.108000E-02 |
| Normal-vs-Asian |
6.03259999731875E-08 |
| Caucasian-vs-AfricanAmerican |
2.055400E-01 |
| Caucasian-vs-Asian |
8.890400E-01 |
| AfricanAmerican-vs-Asian |
2.103000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.26200000005738E-07 |
| Normal-vs-Female |
2.13618012168126E-12 |
| Male-vs-Female |
3.410800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.3890006880315E-11 |
| Normal-vs-Age(41-60Yrs) |
5.19584375524573E-14 |
| Normal-vs-Age(61-80Yrs) |
4.20549999999853E-05 |
| Normal-vs-Age(81-100Yrs) |
5.957300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.879000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.355000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.967600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.903500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.747000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.893400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.32650000000701E-05 |
| Classical-VS-Follicular |
4.041200E-01 |
| Classical-VS-Other |
5.530800E-01 |
| Classical-VS-Normal |
1.17949983113874E-10 |
| Tall-VS-Follicular |
1.421310E-04 |
| Tall-VS-Other |
1.143390E-01 |
| Tall-VS-Normal |
6.13953332617712E-14 |
| Follicular-VS-Other |
8.247200E-01 |
| Follicular-VS-Normal |
2.15469999998996E-05 |
| Other-VS-Normal |
5.228500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.29079999811444E-08 |
| Normal-vs-N1 |
4.47789999968862E-07 |
| N0-vs-N1 |
5.598600E-01 |
|
|
